What is the primary action of Class IC antiarrhythmic drugs used in Atrial Tachycardia?

What is the primary action of Class IC antiarrhythmic drugs used in Atrial Tachycardia?

• A. Blocking potassium channels
• B. Blocking sodium channels
• C. Inhibiting calcium influx
• D. Stimulating adrenergic receptors

Answer: (B)

The primary action of Class IC antiarrhythmic drugs in the treatment of Atrial Tachycardia is the blocking of sodium channels. This mechanism significantly influences cardiac action potentials by slowing down depolarization in phase zero, thereby stabilizing the cardiac membrane and reducing the excitability of the myocardium. As a result, these agents effectively help to control the rapid heart rhythms associated with atrial tachycardia by prolonging the refractory period, ultimately diminishing the likelihood of reentrant circuits that may perpetuate the arrhythmia. In contrast, the other classifications mentioned are associated with different mechanisms of action. Potassium channel blockers, for example, work primarily by prolonging repolarization and the refractory period but are not characteristic of Class IC drugs. Inhibiting calcium influx pertains more to Class IV antiarrhythmics, which predominantly target atrial tissue and nodal tissues, leading to decreased conduction through the AV node. Stimulating adrenergic receptors is typical of sympathomimetic agents, which can actually promote tachycardia rather than treat it.

The primary action of Class IC antiarrhythmic drugs in the treatment of Atrial Tachycardia is the blocking of sodium channels. This mechanism significantly influences cardiac action potentials by slowing down depolarization in phase zero, thereby stabilizing the cardiac membrane and reducing the excitability of the myocardium. As a result, these agents effectively help to control the rapid heart rhythms associated with atrial tachycardia by prolonging the refractory period, ultimately diminishing the likelihood of reentrant circuits that may perpetuate the arrhythmia.

In contrast, the other classifications mentioned are associated with different mechanisms of action. Potassium channel blockers, for example, work primarily by prolonging repolarization and the refractory period but are not characteristic of Class IC drugs. Inhibiting calcium influx pertains more to Class IV antiarrhythmics, which predominantly target atrial tissue and nodal tissues, leading to decreased conduction through the AV node. Stimulating adrenergic receptors is typical of sympathomimetic agents, which can actually promote tachycardia rather than treat it.